Brands: Corlanor · Ivabradine Hydrochloride
Average across 15 priced NDCs. A benchmark of pharmacy acquisition cost - not a retail quote.
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume - Medicaid only, not all-payer.
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Alembic Pharmaceuticals Limited | generic | 8 | SUPPLYING |
| Novadoz Pharmaceuticals LLC | generic | 4 | SUPPLYING |
| Bionpharma Inc. | unknown | 4 | SUPPLYING |
| Amgen, Inc | unknown | 3 | SUPPLYING |
| NorthStar Rx LLC | relabeler | 2 | SUPPLYING |
| Camber Pharmaceuticals, Inc. | generic | 2 | SUPPLYING |
| Ingenus Pharmaceuticals, LLC | unknown | 2 | SUPPLYING |
| Golden State Medical Supply, Inc. | repackager | 2 | SUPPLYING |
| American Health Packaging | repackager | 1 | SUPPLYING |
Shortages, recalls, and registration changes attached to this drug concept.
Presence of Foreign Substance. — Recalling firm: Amgen, Inc. — Nationwide within the United States
Presence of Foreign Substance. — Recalling firm: Amgen, Inc. — Nationwide within the United States
Ivabradine Hydrochloride Tablet — reported in shortage by Amgen Inc.. Therapeutic category: Cardiovascular.
Ivabradine Hydrochloride Tablet — reported in shortage by Amgen Inc.. Therapeutic category: Cardiovascular.
Ivabradine Solution — reported in shortage by Amgen Inc.. Therapeutic category: Cardiovascular.
Ivabradine Solution — reported in shortage by Amgen Inc.. Therapeutic category: Cardiovascular.
